Prothrombin Complex Concentrate in Liver Transplant Surgery: Correction of Therapeutic Anticoagulation and the Coagulopathy of End-Stage Liver Disease: Case Series.

4-factor prothrombin complex concentrate Kcentra end stage liver disease (ESLD) liver transplant anesthesia liver transplant anesthesiology prothrombin complex concentrate (PCC) transfusion - alternative strategies

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2020
Historique:
received: 28 05 2020
accepted: 18 08 2020
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 6 10 2020
Statut: epublish

Résumé

Suggested treatment for active bleeding or invasive procedure prophylaxis has been described in the setting of end-stage liver disease (ESLD) in patients not receiving anticoagulation, and has included fresh frozen plasma (FFP), prothrombin complex concentrates (PCC), platelets, and cryoprecipitate. Today, the therapy for pharmacologically anticoagulated patients with ESLD presenting for liver transplant surgery remains controversial, poorly studied, and physician-dependent. We observed a variety of treatments administered at initiation of liver transplantation to correct acquired coagulopathy at our leading transplant center and present these cases. Three patients receiving preoperative therapeutic anticoagulation with warfarin for acute deep venous thrombosis and/or atrial fibrillation were transfused PCC, FFP, and/or cryoprecipitate for liver or liver-kidney transplant surgery. No thrombotic complications occurred, and one patient required reoperation for hemorrhage. We report data from these cases including estimated blood loss, presence of complications, duration of ICU stay, and length of hospitalization. Perioperative orthotopic liver transplant hematologic management and a review of relevant literature is presented.

Identifiants

pubmed: 33013404
doi: 10.3389/fphar.2020.566433
pmc: PMC7506038
doi:

Types de publication

Case Reports

Langues

eng

Pagination

566433

Informations de copyright

Copyright © 2020 Marshall, Noble and Flores.

Références

Ann Pharmacother. 2015 Aug;49(8):876-82
pubmed: 25986007
Transfusion. 2017 Dec;57(12):3026-3034
pubmed: 28960322
Blood Transfus. 2010 Jul;8(3):149-54
pubmed: 20671873
Liver Transpl. 2018 Aug;24(8):1119-1132
pubmed: 30142249
Crit Care. 2016 Jan 06;20:5
pubmed: 26738468
Transplant Direct. 2018 Oct 26;4(11):e403
pubmed: 30534594
Transfusion. 2014 Oct;54(10 Pt 2):2760-8
pubmed: 24827116
Liver Transpl. 2017 Mar;23(3):396-397
pubmed: 28026110
Dig Dis Sci. 2016 Jun;61(6):1721-7
pubmed: 26725062
Semin Cardiothorac Vasc Anesth. 2017 Sep;21(3):245-251
pubmed: 27837084
Transplantation. 2018 Apr;102(4):578-592
pubmed: 29337842
Hepatol Commun. 2019 Feb 05;3(4):513-524
pubmed: 30976742
Clin Transplant. 2017 Jan;31(1):
pubmed: 27859621
Br J Haematol. 2019 Mar;184(5):808-816
pubmed: 30515764
Int J Organ Transplant Med. 2018;9(3):105-111
pubmed: 30487957
Am J Hematol. 2008 Feb;83(2):137-43
pubmed: 17729241
Clin Transplant. 2018 Dec;32(12):e13435
pubmed: 30375084

Auteurs

Scarlett V Marshall (SV)

Wexner Medical Center, The Ohio State University, Columbus, OH, United States.

Jordan Noble (J)

College of Medicine, The Ohio State University, Columbus, OH, United States.

Antolin S Flores (AS)

Wexner Medical Center, The Ohio State University, Columbus, OH, United States.

Classifications MeSH